王涛, 苑新海, 王海红. 2007-2010年北京市昌平区流行性腮腺炎流行病学分析[J]. 疾病监测, 2011, 26(12): 966-968.
引用本文: 王涛, 苑新海, 王海红. 2007-2010年北京市昌平区流行性腮腺炎流行病学分析[J]. 疾病监测, 2011, 26(12): 966-968.
WANG Tao, YUAN Xin-hai, WANG Hai-hong. Epidemiology of mumps in Changping district in Beijing,2007-2010[J]. Disease Surveillance, 2011, 26(12): 966-968.
Citation: WANG Tao, YUAN Xin-hai, WANG Hai-hong. Epidemiology of mumps in Changping district in Beijing,2007-2010[J]. Disease Surveillance, 2011, 26(12): 966-968.

2007-2010年北京市昌平区流行性腮腺炎流行病学分析

Epidemiology of mumps in Changping district in Beijing,2007-2010

  • 摘要: 目的 了解北京市昌平区流行性腮腺炎(流腮)流行病学特征。 方法 利用描述性研究方法,对中国疾病监测信息报告管理系统中报告的流腮病例进行分析。 结果 2007-2010年北京市昌平区共发生流腮病例1196例,年平均发病率为40.59/10万。发病主要集中在2~8岁,占全部病例的67.14%,5岁组发病率最高;发病有明显地区聚集性,回龙观镇、东小口镇和北七家镇等流动人口聚集的城乡结合部发病较高;以学生和托幼儿童发病为主,占全部病例的73.41%;病例发病集中在5-8月;有免疫史发病占66.05%;针对是否发生发热、腮腺疼痛、头痛、双侧腮腺肿大、并发症以及发热和病程持续时间,不同免疫史病例间差异有统计学意义。 结论 应加强监测,提高实验室检测能力。腮腺炎疫苗即使不能阻止发病但对减轻流腮临床症状可能有一定作用,同时应对腮腺炎疫苗效力进行深入研究。

     

    Abstract: Objective To understand the epidemiological characteristics of mumps in Changping in Beijing and provide scientific evidence for the control and prevention of mumps. Methods Descriptive epidemiological analysis was conducted on the incidence data of mumps in Changping collected from national disease reporting information system from 2007 to 2010.. Results A total of 1196 mumps cases occurred in Changping from 2007 to 2010 with the average annual incidence of 40.59/lakh. Most cases were in age group of 2-8 years, accounting for 67.14% of the total. The incidence in age group of 5 years was highest; The area clustering of the disease was obvious, the incidences were high in townships of Huilongguan, Dongxiaokou and Beiqijia located in zone joining town and country where large number of floating population lived.. Students and children in child care settings were affected mostly, the cases among them accounted for 73.41%. The disease mainly occurred during May-August in a year. The cases in immunized people accounted for 66.05%. The differences on the occurring of fever, parotid pain, headache, bilateral parotid enlargement and complication as well as the duration of fever were significant between the cases with different immunization history. Conclusion It is necessary to strengthen the disease surveillance and improve the laboratory diagnostic capacity. Although mumps vaccine may fail to prevent the disease, the clinical symptoms can be mitigated. In addition, the further study on the efficiency of mumps vaccine should be conducted.

     

/

返回文章
返回